Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. Viewpoint Oct 2014 “We Can” Doesn’t Mean “We Should”: Aggressive Interventions to Prolong Pregnancy Stephen T. Chasen, MD Virtual Mentor. 2014;16(10):842-845. doi: 10.1001/virtualmentor.2014.16.10.oped2-1410. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. Policy Forum Mar 2005 Health Care for Incarcerated Adolescents: Significant Needs with Considerable Obstacles Robert E. Morris, MD Virtual Mentor. 2005;7(3):244-248. doi: 10.1001/virtualmentor.2005.7.3.pfor2-0503. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Medicine and Society Aug 2017 Should Euthanasia Be Considered Iatrogenic? Silvana Barone, MD and Yoram Unguru, MD, MS, MA AMA J Ethics. 2017;19(8):802-814. doi: 10.1001/journalofethics.2017.19.8.msoc1-1708.